Reposted by A/Prof Mastura Monif
NEW in @plosone.org promising #glioblastoma therapeutic target. Dr Matthew Drill & team
@masturamonif.bsky.social @monashuniversity.bsky.social
reveal an alternative pathway with selective targeting to complement existing treatments and/or offer new treatment doi.org/10.1371/jour... #neuroscience
doi.org
Purinergic P2X receptor 7 (P2X7R) inhibition induced cytotoxicity in glioblastoma
Glioblastoma is the most common and aggressive form of primary brain cancer with a median survival of 15 months from diagnosis. The purinergic receptor P2X7 (P2X7R) is a regulator of several cell sign...